C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 31/475 (2006.01) A61K 31/573 (2006.01) A61K 31/675 (2006.01) A61K 31/704 (2006.01) A61K 39/395 (2006.01) A61K 51/10 (2006.01) A61P 35/02 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2626445
Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.
Anderson Darrell R.
Hanna Nabil
Leonard John E.
Newman Roland A.
Rastetter William H.
Biogen Idec Inc.
Idec Pharmaceuticals Corporation
Smart & Biggar
LandOfFree
Therapeutic application of chimeric and radiolabeled... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic application of chimeric and radiolabeled..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic application of chimeric and radiolabeled... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1856674